White House News Manufacturers Of 10 Drugs Chosen For Medicare Price Negotiations Healio

Trump administration unveils Medicare negotiated price cuts for 15 drugs, including Ozempic

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion saved ... Read More

Trump administration says lower prices for 15 Medicare drugs will save taxpayers billions

The Trump administration says pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs after months of negotiations and that it's expected to produce billions in sav ... Read More

Trump admin says drug price negotiations will save Medicare roughly $12 billion

Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced Tuesday ... Read More

Medicare to Cover Obesity Drugs Under Trump Deal for as Little as $50. What You Need to Know

The White House recently announced a landmark deal with pharmaceutical companies Eli Lilly and Nordisk that will impact Medicare beneficiaries and others in the coming months. The agreement cuts ... Read More

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

Topping the list are Novo Nordisk's blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, which are considered one product in the talks since they all share the ... Read More

Trump’s drug pricing push sidelines Medicare negotiation program

As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is ... Read More

Ozempic, Wegovy among new drugs selected for Medicare’s price negotiations

WASHINGTON — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the ... Read More

Lilly, Novo near White House deals to cut obesity drug prices, gain Medicare access, Endpoints News reports

(Reuters) -Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss drugs at $149 per month, in exchange for Medicare coverage, ... Read More

White House nears deal to lower obesity drug prices for Medicare coverage

The White House is expected to announce a deal this week with Eli Lilly and Novo Nordisk that would lower the price of their popular obesity drugs to $149 per month in some cases, according to four ... Read More